Rules of anti-infection therapy for sepsis and septic shock

Chinese Medical Journal
Xiang ZhouYun Long

Abstract

Sepsis is a deadly infection that causes injury to tissues and organs. Infection and anti-infective treatment are the eternal themes of sepsis. The successful control of infection is a key factor of resuscitation for sepsis and septic shock. This review examines evidence for the treatment of sepsis. This evidence is combined with clinical experiments to reveal the rules and a standard flowchart of anti-infection therapy for sepsis. We retrieved information from the PubMed database up to October 2018 using various search terms and their combinations, including sepsis, septic shock, infection, antibiotics, and anti-infection. We included data from peer-reviewed journals printed in English on the relationships between infections and antibiotics. By combining the literature review and clinical experience, we propose a 6Rs rule for sepsis and septic shock management: right patients, right time, right target, right antibiotics, right dose, and right source control. This rule encompasses rational decisions regarding the timing of treatment, the identification of the correct pathogen, the selection of appropriate antibiotics, the formulation of a scientifically based antibiotic dosage regimen, and the adequate control of infectious foc...Continue Reading

References

Dec 1, 1987·Critical Care Medicine·L Chelluri, M S Jastremski
Dec 21, 1984·The American Journal of Medicine·J J SchentagJ W Vance
Oct 1, 1984·The American Journal of Medicine·R D MooreP S Lietman
May 1, 1993·Antimicrobial Agents and Chemotherapy·A ForrestJ J Schentag
Aug 1, 1996·Journal of Pediatric Surgery·R L MossA M Kosloske
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Z Ali, M B Goetz
Jan 24, 1998·JAMA : the Journal of the American Medical Association·S L PrestonM Corrado
Feb 27, 1999·Antimicrobial Agents and Chemotherapy·A D KashubaJ S Bertino
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Apr 20, 2001·Intensive Care Medicine·M F JimenezUNKNOWN International Sepsis Forum
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Apr 20, 2004·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Management Guidelines Committee
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Walter T Linde-Zwirble, Derek C Angus
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Aug 30, 2008·Journal of Critical Care·Arthur R H van ZantenArmand R J Girbes
Dec 6, 2008·Therapeutic Drug Monitoring·Rhonda S ReaHoward Lee
Apr 21, 2009·Clinics in Chest Medicine·L Joseph Wheat
Aug 22, 2009·Chest·Anand KumarUNKNOWN Cooperative Antimicrobial Therapy of Septic Shock Database Research Group
Aug 22, 2009·American Journal of Respiratory and Critical Care Medicine·Ricard FerrerUNKNOWN Edusepsis Study Group
Dec 24, 2009·Critical Care Medicine·Amisha V BarochiaPeter Q Eichacker
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Jared L CrandonDavid P Nicolau
Mar 26, 2010·Intensive Care Medicine·Mathias W PletzTobias Welte
Apr 8, 2010·Critical Care : the Official Journal of the Critical Care Forum·Fabio Silvio TacconeFrédérique Jacobs
May 13, 2010·Critical Care : the Official Journal of the Critical Care Forum·Teresa CardosoAltamiro Costa-Pereira
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Mical PaulLeonard Leibovici
Mar 6, 2012·International Journal of Antimicrobial Agents·João Pedro BaptistaJorge M Pimentel
Dec 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rebecca ZadrogaGlen T Hansen
Jan 29, 2013·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
Feb 19, 2013·American Journal of Surgery·Wai-Nang ChaoMeng-Chih Lee
Jun 12, 2013·The British Journal of Surgery·D L BuckUNKNOWN Danish Clinical Register of Emergency Surgery
Aug 30, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Jan 17, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jason A RobertsUNKNOWN DALI Study

❮ Previous
Next ❯

Citations

Mar 8, 2020·International Journal of Clinical Pharmacy·Khalid Ahmad Al-SunaidarYahaya Prof Hassan
Mar 13, 2021·Journal of Clinical Pharmacy and Therapeutics·Bita ShahramiMojtaba Mojtahedzadeh
Aug 6, 2021·International Journal of Clinical Practice·Praneetha JainShraddha Shetty
Jan 27, 2021·Chinese Medical Journal·Lu WangUNKNOWN China National Critical Care Quality Control Center group

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.